Pharmafocus.com

Pharmafocus Home

Latest Features ( August )
	Competency-based interviewing: Selling your skillset Drawing on your previous triumphs and failures can help you prove you're up to the job. But preparation is the key to success.(more)
	Welcome to the real world Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
	Drug regulation: still room for improvement The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)

Previous Months: July 2008 | June 2008 | May 2008 | April 2008 | March 2008 | February 2008 | January 2008 | December 2007 | November 2007 | October 2007 | September 2007 | August 2007 | July 2007 | June 2007 | May 2007 | April 2007 | March 2007 | February 2007 | January 2007 | December 2006 | November 2006 | October 2006 | September 2006 | August 2006 | July 2006 | June 2006 | May 2006 | April 2006 | March 2006 | February 2006 | January 2006 | December 2005 | November 2005 | October 2005 | September 2005 | August 2005 | July 2005 | June 2005 | May 2005 | April 2005 | March 2005 | February 2005 | January 2005 | December 2004 | November 2004 | October 2004 | September 2004 | August 2004 | July 2004 | June 2004 | May 2004 | April 2004 | March 2004 | February 2004 | January 2004 | December 2003 | November 2003 | October 2003 | September 2003 | August 2003 | July 2003 | June 2003 | May 2003 | April 2003 | March 2003 | February 2003 | January 2003 | December 2002 | November 2002 |

What is RSS?

Novartis becomes generic world leader
Job cuts necessary..(more)

MHRA to get tough on 'unethical' pharma advertising
Blue Guide launched..(more)

FDA panel clears Vioxx return to market
Vioxx scrapes through..(more)

New FDA drug safety board to be more independent
Critics want more..(more)

ADHD latest drugs to be hit by safety warnings
Canada's regulator surprises Shire..(more)

Garnier hints at large-scale cutbacks to global salesforce
Industry-wide cuts on cards..(more)

IMS and Innovex announce UK alliance
Three-year tie-up agreed..(more)

NHS to be key election issue as Blair unveils pledge
Labour highlights progress..(more)

Trusts rewarded for hitting A&E targets
96 trusts hit targets..(more)

Reid admits hospital closures a possibility
BMA criticises claims..(more)

Chronic disease programme needs more work, says think tank
King's Fund advises evaluation..(more)

New UK biotech fundraising initiative declared a win-win
Myners report offers flexibility..(more)

Sanofi-Aventis sponsor cardiovascular research centre
Centre of excellence created..(more)

Roche hepatitis and HIV combination approved
Pegasys sales increase..(more)

More money for PCTs in poor areas
Money for NHS frontline..(more)

Rare side-effect warnings for Strattera
MHRA issues advice..(more)

Audit service launched to judge pharma marketing success
Q2 Audit launches new service..(more)

Schering launches new dermatology company
Intendis aims to be top ten player..(more)

New depression treatment launched in the UK
Efexor main competitor..(more)

'Smarter steroid' Alvesco launched in the UK
Labelling poses problems..(more)

New 'economic damage' offence to beat animal activists
Government cracks down..(more)

BMJ apologises for Prozac accusations
Safety questions raised..(more)

Aspirin plus PPI better than Plavix in patients with GI bleed
Setback for Sanofi-Aventis/BMS..(more)

Lipitor breaks $10 billion annual sales mark
Pfizer impresses with sales growth..(more)

Humira tipped for blockbuster status in 2005
Generics threaten Abbott growth..(more)

Overdose deaths lead to co-proxamol withdrawal
MHRA orders phased withdrawal..(more)

Merck hit by US patent blow
Fosamax loses out..(more)

AstraZeneca remains strong despite setbacks
AZ announces positive results..(more)

Are you a Pharmafocus subscriber?

Subscribe Now

Visit our sister sites:

InPharm.com

Pharmafile.com

Pharmafocus.com © 2006 Pharmafile Ltd.

Website Terms & Conditions